Slides - Clinical Trial Results .org

More documents

Recommendations

Info

<strong>Results</strong>: ITT Cohort Hospital and 30-Day Endpoints GIK (n=411) Placebo (n=460) Risk Ratio (95% CI) P Value Progression to MI 49% 53% 0.88 (0.66-1.13) 0.28
<strong>Results</strong>: ITT Cohort Hospital and 30-Day Endpoints GIK (n=411) Placebo (n=460) Risk Ratio (95% CI) P Value Progression to MI 49% 53% 0.88 (0.66-1.13) 0.28 30-Day Mortality 4% 6% 0.72 (0.40-1.29) 0.27
Page 1 and 2: Results of the IMMEDIATE (Immediate
Page 3 and 4: Carl Apstein, MD, FACC The IMMEDIAT
Page 5 and 6: Background: Rationale for Placebo-C
Page 7 and 8: Methods: Basic Features of Study De
Page 9 and 10: Methods: Pre-Specified Endpoints
Page 11 and 12: Methods: Exclusion Criteria • HF
Page 13 and 14: Methods: Analysis • Sample size c
Page 15 and 16: Results: Screening and Enrollment o
Page 17: Results: Time from Ischemic Symptom
Page 21 and 22: Results: ITT Cohort Hospital and 30
Page 23 and 24: Results: Cohort Presenting with ST
Page 25 and 26: Results: Cohort Presenting with ST
Page 27 and 28: Median infarct size (IQR) Results:
Page 29 and 30: Median infarct size (IQR) Results:
Page 31 and 32: Limitations • Primary endpoint pr
Page 33 and 34: James Atkins • Assaad Sayah • M

Slides - Clinical Trial Results .org

Create successful ePaper yourself

Delete template?

Save as template?